Biotech Acquired and Funded Websites

altad.org— We investigate alternatives to conventional antibiotics, from bacteriophages and antimicrobial peptides to probiotics and virulence-targeting agents, to bypass the problem of resistance. Through chemical biology and synthetic biology, we harness host-microbe interactions to build a safer, post-antibiotic future for human health. Show more

ceryvyn.com— Ceryvyn is a biotech company focused on developing CYV-101, a fusion protein targeting lymphangioleiomyomatosis (LAM), a rare progressive lung disease.

forgen.bio— built for industrial reality. With direct access to one of Europe's most advanced biocatalysis facilities, we have grown a portfolio of proven molecules, and we keep adding to it. Our mission is simple: to unlock nature's full industrial potential. Show more

witiipharma.com— MECHANISM DRIVEN THERAPEUTICS RESTORING HEALING IN CHRONIC DIABETIC WOUNDS At WiTii Pharmaceuticals, we are redefining how chronic diabetic wounds are treated; not by adding more signals, but by restoring the biological environment that allows healing to occur. Our work combines drug repurposing with mechanism-driven innovation to unlock new therapeutic potential from known compounds applied in entirely new ways. Show more

haptena.com— Haptena Therapeutics: where precision oncology meets next-generation immune innovation. Our mission is to bridge the precision of targeted therapies and the transformative potential of immune-based treatments to deliver more durable options for patients with some of the most challenging tumors. Show more

skeletalis.bio— Elevating musculoskeletal health through targeted delivery. We’re translating insights in bone biology into targeted therapies that protect and rebuild bone—without shutting down the body’s natural bone remodeling. Show more

gcpclinplus.com— GCP ClinPlus is a clinical research organization (CRO) specializing in drug development and clinical trial services in China, including clinical operations, biometrics, and regulatory affairs.

kaldur.org— Each year, millions suffer from cardiac arrest and hundreds of thousand of children suffer from neonatal asphyxia (lack of oxygen at birth). To minimise the harm from this, external or internal cooling is used, activating the mild hypothermia response, a detailed and highly regulated process in the body . Our goal is to understand the genetic background of this response in detail an develop medications to manipulate it. Show more

eyexora.com— a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model

perseveretherapeutics.com— We are on a mission to improve therapeutic outcomes for cancer patients with misetionamide, a tumor-cell selective agent with a truly novel mechanism of action.

deepcyte.bio— We predict and explain how drugs cause toxicity, before they reach patients.

countablelabs.com— Countable PCR delivers direct, precise, and sensitive detection when it matters most.

immitrabio.com— Immitra Bio is developing an in-vivo stem cell therapy platform for rare genetic diseases, aiming to replace complex transplants with a single off-the-shelf treatment.

ternarytx.co.uk— TernaryTx uses AI to design protein glue molecules for drug discovery, screening millions of compounds to identify hits and detect small structural changes that lead to significant differences in activity.

foamlab.co— We are an interdisciplinary team bringing together backgrounds in biology, engineering, product development, and sustainability. Our motto: material innovation that works with nature. Show more

interna.bio— We develop a unique delivery modality for getting DNA, RNA, proteins, peptides, and other large molecules into the cell cytoplasm, for use in a wide range of therapeutic areas, and in a variety of different modes of administration. Our solution We are introducing the molecular nano motor, or MNM, a novel technology for the intracellular delivery of large molecules, powered by the energy intrinsic to all cell membranes. Show more

infuselifescience.com— infuse Life Science, Inc. is a life science company. Show more

syntax-bio.com— Syntax Bio's discovery platform overcomes the longstanding challenges in stem cell-derived therapies by directly controlling and accelerating cell differentiation. Syntax’s proprietary Cellgorithm technology mimics human development to generate a wide diversity of functional cell types to enable new product opportunities. Show more

responsepharmaceuticals.com— Response Pharmaceuticals is a biopharmaceutical company developing RDX-002, a novel small molecule iMTP inhibitor, for weight management in patients discontinuing GLP-1 agonists and for the treatment of antipsychotic-induced weight gain.

resonate.bio— Resonate Bio is a University of Vienna spinout and Vienna-based biotechnology company developing an AI-enabled NMR platform for structure-guided drug discovery.